AYMHY
Live / Applied — Final refusal mailed (as of 12 Aug 2026)
What this means for you
Not registered yet, but its 08 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99328385
- Mark type
- Word mark
- Filed
- 08 Aug 2025
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of metabolic diseases and orphan diseases, namely, overactivation of insulin receptor by insulin or insulin-like substances, including congenital hyperinsulinism, tumor hyperinsulinism caused by insulinomas and non-islet cell tumors (IGF-2 mediated), transient hypoglycemia (e.g., perinatal stress or related causes), post-bariatric hyperinsulinism (PBHI), post-gastrectomy hyperinsulinism, nesidioblastosis, activating insulin receptor autoantibodies, insulin autoimmune syndrome (IAS), Hirata's disease, monogenic diabetes
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Rezolute, Inc., Redwood City, CA, US
Prosecution history
- 12 Aug 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 12 Aug 2026 — FINAL REFUSAL E-MAILED
- 12 Aug 2026 — FINAL REFUSAL WRITTEN
- 10 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 03 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Dec 2025 — NON-FINAL ACTION E-MAILED
- 23 Dec 2025 — NON-FINAL ACTION WRITTEN
- 23 Dec 2025 — ASSIGNED TO EXAMINER
- 08 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 08 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Aug 2025 — NEW APPLICATION ENTERED